1. Fenretinide combines perturbation of signaling kinases, cell–extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells. (17th August 2022) Authors: Wang, Daren; Pei, Ping; Shea, Fortune F; Bissonnette, Caroline; Nieto, Kari; Din, Corrine; Liu, Yayuan; Schwendeman, Steven P; Lin, Yan X; Spinney, Richard; Mallery, Susan R Journal: Carcinogenesis Issue: Volume 43:Number 9(2022) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗